Related Experiment Video
Updated: Feb 3, 2026

Obtaining Primary Osteocytes Through Murine Calvarial Fractionation of GFP-Expressing Osteocytes
Published on: June 2, 2020
Selective β2-adrenoreceptor signaling regulates osteoclastogenesis via modulating RANKL production and neuropeptides
Hengxing Liang1, Yuanyuan Zeng2, Yunzhi Feng2
1Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Abstract:
The β2-adrenergic receptor (β2-AR) signaling on bone cells is the major contributor in the effect of the sympathetic nervous system on bone turnover. However, it remains unclear whether receptor activator of nuclear factor κ-Β ligand (RANKL) modulation and neuropeptides expression in osteocytes are responsible for the mechanism. This study used β2-AR stimulation to investigate cell cycle and proliferation, the gene and protein expression of RANKL, and osteoprotegerin (OPG), as well as neuropeptides regulation in osteocytic MLO-Y4 cells. Clenbuterol (CLE; a β2-AR agonist) slightly promoted the growth of MLO-Y4 cells in a concentration-dependent effect but had no effect on the proliferation index. And the concentration of 10-8 M showed a significant increase in the S-phase fraction on day 3 in comparison with the control. Additionally, CLE-promoted osteoclast formation and bone resorption in osteocytic MLO-Y4 cell-RAW264.7 cell cocultures. RANKL expression level and the ratio of RANKL to OPG in MLO-Y4 cells were enhanced in CLE treatment but were rescued by blocking β2-AR signaling. However, neuropeptide Y and α-calcitonin gene-related peptide, two neurogenic markers, were inhibited in CLE treatment of MLO-Y4 cells, which was reversed by a β2-AR blocker. The results indicate that osteocytic β2-AR plays an important role in the regulation of RANKL/OPG and neuropeptides expression, and β2-AR signaling in osteocytes can be used as a new valuable target for osteoclast-related pathologic disease.
Insights
Stimulating beta2-adrenergic receptors (β2-AR) in osteocytes influences bone turnover by modulating RANKL/OPG and neuropeptides. This suggests β2-AR signaling is a potential therapeutic target for bone diseases.
Area of Science:
- Bone Biology and Endocrinology
- Cellular and Molecular Medicine
Background:
- Sympathetic nervous system influences bone turnover primarily through beta2-adrenergic receptor (β2-AR) signaling on bone cells.
- The precise mechanisms involving receptor activator of nuclear factor κ-Β ligand (RANKL) modulation and neuropeptide expression in osteocytes remain largely unelucidated.
Purpose of the Study:
- To investigate the role of β2-AR stimulation in osteocytic MLO-Y4 cells.
- To examine the effects on cell cycle, proliferation, RANKL and osteoprotegerin (OPG) expression, and neuropeptide regulation.
Main Methods:
- Osteocytic MLO-Y4 cells were treated with clenbuterol (CLE), a β2-AR agonist, and a β2-AR blocker.
- Cell cycle analysis, proliferation assays, gene and protein expression analysis of RANKL and OPG were performed.
- Co-culture systems with RAW264.7 cells were used to assess osteoclast formation and bone resorption.
Main Results:
- CLE promoted MLO-Y4 cell growth and increased S-phase fraction, but did not affect the proliferation index.
- CLE enhanced osteoclast formation, bone resorption, RANKL expression, and the RANKL/OPG ratio in osteocytes.
- CLE inhibited neuropeptide Y and α-calcitonin gene-related peptide expression, effects reversed by β2-AR blockade.
Conclusions:
- Osteocytic β2-AR signaling plays a significant role in regulating RANKL/OPG balance and neuropeptide expression.
- β2-AR signaling in osteocytes represents a potential therapeutic target for managing osteoclast-related bone diseases.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
What is Cell Signaling?
Cell Specific Gene Expression
Regulation of Expression at Multiple Steps
Bacterial Signaling

